Search results for "Positive"

showing 10 items of 1875 documents

Antigen-Driven T-Cell Selection in Patients with Cervical Cancer as Evidenced by T-Cell Receptor Analysis and Recognition of Autologous Tumor

2002

ABSTRACTWe characterized the T-cell receptor (TCR) repertoire in freshly harvested tumor lesions, in short-term-expanded CD4+tumor infiltrating lymphocytes (TIL) as well as in CD4+and CD8+peripheral blood lymphocytes (PBL) from three patients with cervical cancer. Skewing of the T-cell repertoire as defined by measuring the length of the complementarity-determining region 3 (CDR3) of the TCR VA and VB chains was observed in CD8+PBL, in freshly harvested tumor tissue, as well as in CD4+TIL. Comparative analysis of the TCR repertoire revealed unique monoclonal TCR transcripts within the tumor lesion which were not present in PBL, suggesting selection of TCR clonotypes due to antigenic stimula…

CD4-Positive T-LymphocytesMicrobiology (medical)medicine.medical_treatmentClinical BiochemistryImmunologyReceptors Antigen T-CellUterine Cervical Neoplasmschemical and pharmacologic phenomenaCD8-Positive T-LymphocytesBiologyEpitopeEpitopesLymphocytes Tumor-InfiltratingImmune systemAntigenAntigens NeoplasmExperimental Clinical InvestigationmedicineHumansImmunology and AllergyTumor-infiltrating lymphocytesT-cell receptorhemic and immune systemsImmunotherapyComplementarity Determining RegionsImmunologyT cell selectionFemaleCD8Clinical and Vaccine Immunology
researchProduct

Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain

2009

Adoptive transfer of T lymphocytes transduced with a T cell receptor (TCR) to impart tumor reactivity has been reported as a potential strategy to redirect immune responses to target cancer cells (Schumacher, T.N. 2002. Nat. Rev. Immunol. 2:512-519). However, the affinity of most TCRs specific for shared tumor antigens that can be isolated is usually low. Thus, strategies to increase the affinity of TCRs or the functional avidity of TCR-transduced T cells might be therapeutically beneficial. Because glycosylation affects the flexibility, movement, and interactions of surface molecules, we tested if selectively removing conserved N-glycoslyation sites in the constant regions of TCR alpha or …

CD4-Positive T-LymphocytesModels MolecularAdoptive cell transferGlycosylationCD3ImmunologyReceptors Antigen T-Cellchemical and pharmacologic phenomenaEnzyme-Linked Immunosorbent AssayStreptamerBiologyArticleCell Line03 medical and health sciencesMice0302 clinical medicineImmune systemTetramerAntigenModelsCell Line TumorNeoplasmsReceptorsImmunology and AllergyAnimalsHumansAvidity030304 developmental biology0303 health sciencesTumorReverse Transcriptase Polymerase Chain ReactionT-cell receptorTemperatureMolecularhemic and immune systemsT-CellFlow CytometryMolecular biologyAdoptive TransferAntigenbiology.protein030215 immunologyProtein Binding
researchProduct

In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthroug…

2022

AbstractSince neutrophil extracellular traps formation (NET-osis) can be assessed indirectly by treating healthy neutrophils with blood-derived fluids from patients and then measuring the NETs response, we designed a pilot study to convey high-dimensional cytometry of peripheral blood immune cells and cytokines, combined with clinical features, to understand if NET-osis assessment could be included in the immune risk profiling to early prediction of clinical patterns, disease severity, and viral clearance at 28 days in COVID-19 patients. Immune cells composition of peripheral blood, cytokines concentration and in-vitro NETosis were detected in peripheral blood of 41 consecutive COVID-19 inp…

CD4-Positive T-LymphocytesMultidisciplinaryCOVID-19 VaccinesInterleukin-6SARS-CoV-2COVID-19 VaccineCOVID-19Pilot ProjectsCD8-Positive T-LymphocyteLeukocyte Common AntigenCD8-Positive T-LymphocytesCOVID-19 Drug TreatmentCD4-Positive T-LymphocyteCytokinesHumansLeukocyte Common AntigensPilot ProjectCytokine
researchProduct

Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.

1999

Myelin basic protein (MBP)-reactive T cells may play an important role in the autoimmune pathogenesis of multiple sclerosis (MS). MBP-reactive T cells can be specifically targeted by T cell vaccination, a procedure whereby MS patients are immunized with attenuated autologous MBP reactive T cells. T cell vaccination induces immune responses to the vaccine cells together with a depletion of MBP reactive T cells. Forty-nine MS patients were treated with T cell vaccination in an extended phase I trial to study the safety, immune responses and clinical effects of T cell vaccination. In the present paper the immune responses towards the vaccine cells were characterized. Substantial long-term in v…

CD4-Positive T-LymphocytesMultiple SclerosisT-LymphocytesImmunologyT-cell vaccinationLymphocyte ActivationInterleukin 21Immunology and AllergyMedicineCytotoxic T cellHumansIL-2 receptorAntigen-presenting cellImmunity CellularVaccinesCD40biologyClinical Trials Phase I as Topicbusiness.industryVaccinationMyelin Basic ProteinNatural killer T cellLymphocyte SubsetsVaccines InactivatedCTLA-4ImmunologyAntibody Formationbiology.proteinCytokinesImmunotherapybusinessJournal of autoimmunity
researchProduct

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

2003

AbstractCoupling of ovalbumin (OVA) to anti–DEC-205 monoclonal antibody (mAb) (αDEC) induced the proliferation of OVA-specific T cells in vivo. Expansion was short-lived, caused by dendritic cells (DCs), and rendered T cells anergic thereafter. Phenotypic analysis revealed the induction of CD25+/CTLA-4+ T cells suppressing proliferation and interleukin-2 (IL-2) production of effector CD4+ T cells. The findings were supported by 2 disease models: (1) CD4+ T-cell–mediated hypersensitivity reactions were suppressed by the injection of αDEC-OVA and (2) the application of hapten-coupled αDEC-205 reduced CD8+ T-cell–mediated allergic reactions. Thus, targeting of antigens to immature DCs through …

CD4-Positive T-LymphocytesOvalbuminT-LymphocytesImmunologyCD8-Positive T-LymphocytesDermatitis ContactLymphocyte ActivationBiochemistryMiceInterleukin 21Antigens CDHypersensitivityAnimalsCytotoxic T cellCTLA-4 AntigenHypersensitivity DelayedLymphocyte CountIL-2 receptorAntigensAntigen-presenting cellAntigen PresentationMice Inbred BALB CCD40biologyAntibodies MonoclonalReceptors Interleukin-2Dendritic CellsCell BiologyHematologyDendritic cellNatural killer T cellAntigens DifferentiationCell biologyImmunologyInterleukin 12biology.proteinInterleukin-2HaptensBlood
researchProduct

PD-1 signalling in CD4+T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolera…

2010

Summary The ultimate outcome of T-cell recognition of peptide–major histocompatibility complex (MHC) complexes is determined by the molecular context in which antigen presentation is provided. The paradigm is that, after exposure to peptides presented by steady-state dendritic cells (DCs), inhibitory signals dominate, leading to the deletion and/or functional inactivation of antigen-reactive T cells. This has been utilized in a variety of models providing peptide antigen in soluble form in the absence of adjuvant. A co-inhibitory molecule of considerable current interest is PD-1. Here we show that there is the opportunity for the PD-1/PD-L1 interaction to function in inhibiting the T-cell r…

CD4-Positive T-LymphocytesOvalbuminTransgeneProgrammed Cell Death 1 ReceptorImmunologyAntigen presentationMice TransgenicCell SeparationCD8-Positive T-LymphocytesBiologyLymphocyte ActivationMajor histocompatibility complexMiceImmune systemBlocking antibodyImmune ToleranceAnimalsImmunology and AllergyT-cell receptorOriginal ArticlesFlow CytometryAntigens DifferentiationPeptide FragmentsCell biologyMice Inbred C57BLTolerance inductionPhenotypeImmunologybiology.proteinCD8Signal TransductionImmunology
researchProduct

TLR2 and Dectin-1 Signaling in Mouse Hematopoietic Stem and Progenitor Cells Impacts the Ability of the Antigen Presenting Cells They Produce to Acti…

2020

Microbial recognition by pattern recognition receptors (PRRs) expressed on hematopoietic stem and progenitor cells (HSPCs) not only activates myelopoiesis but also programs the function of the monocytes and macrophages they produce. For instance, changes in HSPC programming modify the ability of macrophages derived from them to produce inflammatory cytokines. While HSPCs exposed to a TLR2 agonist give rise to tolerized macrophages (lower proinflammatory cytokine production), HSPCs treated with Dectin-1 ligands produce trained macrophages (higher proinflammatory cytokine production). However, nothing is known about the impact of HSPC exposure to microbes on the function of antigen presenting…

CD4-Positive T-LymphocytesOvalbuminhematopoietic stem and progenitor cellsCD4 T cellsAntigen-Presenting CellsMice Transgenicantigen presenting cellsLymphocyte Activationinnate immune memoryProinflammatory cytokineLipopeptidesCandida albicansAnimalsTLR2Lectins C-TypeProgenitor cellAntigen-presenting celllcsh:QH301-705.5CD86CD40biologyChemistryCommunicationHistocompatibility Antigens Class IIZymosanGeneral MedicineTh1 CellsHematopoietic Stem CellsAcquired immune systemToll-Like Receptor 2Cell biologyMice Inbred C57BLlcsh:Biology (General)biology.proteinCytokinesTh17 CellsMyelopoiesisCD80Dectin-1Signal TransductionCells
researchProduct

Characterization of T–cell subclasses and NK–cells in lysosomal disorders by immuno–electron microscopy

1994

Previous studies have shown that B and T lymphocytes are affected in lysosomal disorders. The aim of this study was to investigate the involvement of subclasses of T lymphocytes and natural killer cells in lysosomal diseases. CD4+, CD8+, and CD56+ cells were immunomagnetically separated from peripheral blood mononuclear cells in 10 patients with various lysosomal diseases--including one patient each with infantile, late infantile, and juvenile neuronal ceroid-lipfuscinoses, two patients with mucopolysaccharidosis (MPS) type I and four patients with MPS type III, and one patient with mucolipidosis type II; all lymphocytes were studied by light and electron microscopy. Respective vacuolar or …

CD4-Positive T-LymphocytesPathologymedicine.medical_specialtyHistologyT-LymphocytesMucopolysaccharidosisT cellImmunoblottingCD8-Positive T-LymphocytesBiologyPathology and Forensic MedicineNatural killer cellPhysiology (medical)Lysosomal storage diseasemedicineHumansMicroscopy ImmunoelectronT lymphocyteMucopolysaccharidosesmedicine.diseaseKiller Cells Naturalmedicine.anatomical_structureNeurologyNeuronal ceroid lipofuscinosisNeurology (clinical)I-cell diseaseLysosomesCD8Neuropathology and Applied Neurobiology
researchProduct

Miltefosine Efficiently Eliminates Leishmania major Amastigotes from Infected Murine Dendritic Cells without Altering Their Immune Functions▿

2009

ABSTRACT As a treatment for leishmaniasis, miltefosine exerts direct toxic effects on the parasites. Miltefosine also modulates immune cells such as macrophages, leading to parasite elimination via oxidative radicals. Dendritic cells (DC) are critical for initiation of protective immunity against Leishmania through induction of Th1 immunity via interleukin 12 (IL-12). Here, we investigated the effects of miltefosine on DC in Leishmania major infections. When cocultured with miltefosine for 4 days, the majority of in vitro -infected DC were free of parasites. Miltefosine treatment did not influence DC maturation (upregulation of major histocompatibility complex II [MHC II] or costimulatory m…

CD4-Positive T-LymphocytesPhosphorylcholineAntigen presentationAntiprotozoal AgentsLeishmaniasis CutaneousApoptosisBiologyCD8-Positive T-LymphocytesMicrobiologyMiceImmune systemmedicineAnimalsPharmacology (medical)Leishmania majorAntigen-presenting cellMechanisms of Action: Physiological EffectsCells CulturedCell ProliferationLeishmania majorPharmacologyMiltefosineDendritic cellDendritic Cellsbiology.organism_classificationLeishmaniaMice Inbred C57BLInfectious DiseasesImmunologyInterleukin 12medicine.drug
researchProduct

Functionalized Polystyrene Nanoparticles Trigger Human Dendritic Cell Maturation Resulting in Enhanced CD4+T Cell Activation

2012

Nanoparticles (NP) represent a promising tool for biomedical applications. Here, sulfonate- and phosphonate-functionalized polystyrene NP are analyzed for their interaction with human monocyte-derived dendritic cells (DC). Immature dendritic cells (iDC) display a higher time- and dose-dependent uptake of functionalized polystyrene NP compared to mature dendritic cells (mDC). Notably, NP induce an enhanced maturation of iDC but not of mDC (upregulation of stimulatory molecules and cytokines). NP-triggered maturation results in a significantly enhanced T cell stimulatory capacity (increased CD4(+) T cell proliferation and IFN-γ production), indicating a shift to a pronounced Th1 response. Imm…

CD4-Positive T-LymphocytesPolymers and Plasticsmedicine.medical_treatmentT cellOrganophosphonatesNanoparticleBioengineeringLymphocyte ActivationFunctionalized polystyreneBiomaterialsInterferon-gammachemistry.chemical_compoundDownregulation and upregulationMaterials ChemistrymedicineHumansImmunologic FactorsMicroscopy ConfocalCd4 t cellChemistryDendritic CellsImmunotherapyDendritic cellCell biologymedicine.anatomical_structureImmunologyCytokinesNanoparticlesPolystyrenesPolystyreneSulfonic AcidsBiotechnologyMacromolecular Bioscience
researchProduct